Parallax Volatility Advisers, L.P. - AKARI THERAPEUTICS PLC ownership

AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 14 filers reported holding AKARI THERAPEUTICS PLC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Parallax Volatility Advisers, L.P. ownership history of AKARI THERAPEUTICS PLC
ValueSharesWeighting
Q2 2019$15,000
-44.4%
7,5000.0%0.00%
Q1 2019$27,000
+125.0%
7,5000.0%0.00%
Q4 2018$12,000
-36.8%
7,5000.0%0.00%
Q3 2018$19,000
+26.7%
7,5000.0%0.00%
Q2 2018$15,000
+7.1%
7,5000.0%0.00%
Q1 2018$14,000
-56.2%
7,5000.0%0.00%
Q4 2017$32,0007,5000.00%
Other shareholders
AKARI THERAPEUTICS PLC shareholders Q3 2018
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 7,941,867$1,443,0371.26%
Omnia Family Wealth, LLC 782,372$142,1570.11%
NEA Management Company, LLC 452,167$82,1590.01%
Hikari Power Ltd 130,821$240.00%
Bryn Mawr Capital Management, LLC 100,000$18,1700.00%
GEODE CAPITAL MANAGEMENT, LLC 30,264$5,4950.00%
MILLENNIUM MANAGEMENT LLC 261,192$470.00%
Renaissance Technologies 283,550$520.00%
LPL Financial LLC 134,453$24,4300.00%
JPMORGAN CHASE & CO 237$00.00%
View complete list of AKARI THERAPEUTICS PLC shareholders